Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets (Parenthetical)

v3.23.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Restricted cash $ 43,835 $ 50,845
Notes receivable, net $ 574,318 $ 552,490
Preferred stock, par value $ 0.01 $ 0.01
Preferred stock, shares authorized 10,000,000 10,000,000
Variable Interest Entity, Primary Beneficiary [Member]    
Restricted cash $ 22,116 $ 19,461
Notes receivable, net $ 373,270 $ 354,403
Class A Common Stock [Member]    
Common Stock, par value $ 0.01 $ 0.01
Common stock, shares authorized 30,000,000 30,000,000
Common stock, shares issued 12,204,198 12,165,825
Common stock, shares outstanding 12,204,198 12,165,825
Class B Common Stock [Member]    
Common Stock, par value $ 0.01 $ 0.01
Common stock, shares authorized 4,000,000 4,000,000
Common stock, shares issued 3,664,117 3,664,117
Common stock, shares outstanding 3,664,117 3,664,117